Fatty acids and brain peptides

Peptides

Volumn 19, Issue 2, 1998, Pages 407-419

  Yehuda, Shlomo ^a   Rabinovitz, Sharon ^a   Carasso, Ralph L ^b   Mostofsky, David I ^c  

^a BAR ILAN UNIVERSITY   (Israel)

^b HILLEL YAFFE MEDICAL CENTER   (Israel)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Linolenic; Fatty acids; Learning; Linoleic; n 3; n 6; Neuronal membrane; Pain; Ratio; Releasing factors; Thermoregulation

Indexed keywords

FATTY ACID; PEPTIDE; RELEASING FACTOR;

AMINO ACID METABOLISM; CENTRAL NERVOUS SYSTEM; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; LEARNING; LIPID ANALYSIS; NERVE CELL MEMBRANE; NEUROTRANSMISSION; PRIORITY JOURNAL; REVIEW; THERMOREGULATION;

ALPHA-LINOLENIC ACID; ANIMALS; ARACHIDONIC ACID; BRAIN; CHOLESTEROL; CYTOCHROME P-450 ENZYME SYSTEM; FATTY ACIDS; HUMANS; LINOLEIC ACID; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; PROSTAGLANDINS; SLEEP;

EID: 0032006679     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00295-7     Document Type: Review

References (168)

1. Akabayashi A., Zaia C. T., Silva I., Chae H. J., Leibowitz S. F. Neuropeptide Y in the arcuate nucleus is modulated by alternations in glucose utilization. Brain Res. 621:1993;343-348.
2. Alessio M. L., Leger C. L., Rasolonjanahary R., Wandscheer D. E., Clauser H., Enjalbert A., Kordon C. Selective effect of a diet-induced decrease in the arachidonic acid membrane-phospholipid content on in vitro phospholipase C and adenylate cylase-mediated pituitary response to angiotensin II. Neuroendocrinology. 60:1994;400-409.
3. Alkayed N. J., Narayanan J., Gebremedhin D., Medhora M., Roman R. J., Harder D. R. Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes. Stroke. 27:1996;971-979.
4. Amruthesh S. C., Flack J. R., Ellis E. F. Brain synthesis and cerebrovascular action of epoxygenase metabolites of arachidonic acid. J. Neurochem. 58:1992;503-510.
5. Arey E. J., Freeman M. E. Activity of vasoactive intestinal peptide and serotonin in the paraventricular nucleus reflects the periodicity of the endogenous stimulatory rhythm regulating prolactin secretion. Endocrinology. 131:1992;736-742.
6. Attwell D., Miller B., Sartantis M. Arachidonic acid as a messenger in the central nervous system. Semin. Neurosci. 5:1993;159-169.
7. Bank W. A., Kastin A. J., Rappaport S. I. Permeability of blood-brain barrier to circulating free fatty acids. Yehuda S., Mostosky D. Handbook of essential fatty acid biology, biochemistry physiology, and behavioral neurobiology. 1997;1-14 Humana Press, New York.
8. Baranowska B., Radizikowska M., Wasilewska-Dziubinska E. Prolactin and LH release in response to vasoactive intestinal peptide (VIP) administration in spontaneously hypertensive and normotensive rats. Endokrynol. Pol. 43:1992;137-144.
9. Barb C. R., Kraeling R. R., Rampacek G. B. Glucose and free fatty acid modulation of growth hormone and luteinizing hormone secretion by cultures porcine pituitary cells. J. Anim. Sci. 73:1995;1416-1423.
10. Behan D. P., Grigoriadis D. E., Lovenberg T., Chalmers D., Heinrichs S., Liaw C., De Souza E. B. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein implications for the treatment of CNS disorders . Mol. Psychiat. 1:1996;265-277.
11. Bergelson L. D. Dynamic lipid heterogeneity and receptor events. Mol. Membr. Biol. 12:1995;125-129.
12. Bourre J. M., Dumont O., Piciotti M., Clement M., Chaudiere J., Bonneil M., Halbone G., Lafont H., Pascal G., Durand G. Essentially of w3 fatty acids for brain structure and function. World Rev. Nutr. 66:1991;103-117.
13. Bourre J. M., Pascal G., Durand G., Masson M., Dumont O., Piciotti M. Alternations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodenrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty-acids. J. Neurochem. 43:1984;342-348.
14. Bourre J. M., Francois M., Youyou A., Dumont O., Piciotti M., Pascal G., Durand G. The effect of dietary α-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J. Nutr. 119:1989;1880-1892.
15. Bredow S., Kacsoh B., Obal F. Jr, Fang J., Krueger J. M. Increase of prolactin in the rat hypothalamus after intracerebroventricular injection of VIP or PACAP. Brain. Res. 660:1994;301-308.
16. Cambromero J. C., Rivas F. J., Borrell J., Guaza C. Role of arachidonic acid metabolism on corticotropin-releasing factor (CRF)-release induced by interleukin-1 from superfused rat hypothalami. J. Neuroimmunol. 39:1992;57-66.
17. Canonico P. L. Growth hormone relaeasing factor (GRF) increases free arachidonate levels in the pituitary a role for lipoxygenase products . Life Sci. 38:1986;267-272.
18. Canonico P. L. D-2 dopamine receptor activation reduces free [3H] arachidonate release induced by hypophysiotropic peptides in anterior pituitary cells. Endocrinology. 125:1989;1180-1186.
19. Canonico P. L., Judd A. M., Koike K., Valsenegro C. A., MacLeod R. M. Arachidonate stimulates prolactin release in vitro a role for the fatty acid and its metabolites as intracellular regulator (s) in mammotrophs . Endocrinology. 116:1985;218-225.
20. Canonico P. L., Speciale C., Sortino M. A., Cronin M. J., MacLeo R. M., Scapagnini U. Growth hormone releasing factor (GRF) increases free arachidonate levels in the pituitary; a role for lipoxygenase products. Life Sci. 38:1986;267-272.
21. Carmena M. J., Hueso C., Solano R. M., Prieto J. C. Differential effect of arachidonic acid on the vasoactive intestinal peptide receptor/effector system in rat prostatic epithelium during sexual maturation. Peptides. 13:1992;1117-1122.
22. Casanueva F. F., Villaneuva L., Dieguez C., Diaz Y., Carbranes J. A., Szoke B., Scanlon M. F., Schally A. V., Fernandez-Cruz A. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. J. Clin. Endocrinol. Metab. 65:1987;634-642.
23. Caspuglio R., Marinesco S., Baubet V., Bonnet C., el Kafi B. Evidence for a sleep-promoting influence of stress. Adv. Neuroimmunol. 5:1995;145-154.
24. Catalan R. E., Martinez A. M., Aragones M. D., Robles A., Miguel B. G. Substance P induces alterations on cerebral lipids involved in membrane fluidity. Biochem. Biophys. Res. Commun. 144:1987;232-237.
25. Catalan R. E., Martinez A. M., Aragones M. D., Robles A., Miguel B. G. Dual mechanism of phosphatidylinolsitol hydrolysis by substance P in brain. Eur. J. Biochem. 172:1988;547-552.
26. Catalan R. E., Martinez A. M., Miguel B. G., Robles A., Aragones M. D. Somatostatin effects on the cyclic AMP system and lipid metabolism in mouse brain. Neurochem. Res. 11:1986;497-504.
27. Chang J. P., Abele J. T., Van Goor F., Wong A. O. L. Role of arachidonic acid and calmodulin in mediating dopamine D1- and GnRH-stimulated growth hormone release in goldfish pituitary cells. Gen. Comp. Endocrinol. 102:1996;88.
28. Chen F., OwDorisio M. S., Hermann G., Hayes J., Malarkey W. B., Dorisio T. M. Mechanisms of action of long-acting analog of somatostatin. Regul. Pept. 44:1993;285-295.
29. Chen H. Protective effect of thyrotropin-releasing hormone against lipid peroxidation injury during traumatic shock in rats. Chung Hua I Hsueh Tsa Chih. 71:1991;438-440.
30. Clandinin M. T., Jumpsen J., Suh M. Relationship between fatty acid accretion, membrane composition, and biologic functions. J. Pediatr. 125:1994;S25-S32.
31. Clandinin M. T., Cheema S., Field C. J., Garg L., Venkatraman J., Clandinin T. R. Dietary fat exogenous determination of membrane structure and cell function . FASEB. 5:1991;2701-2709.
32. Cook J. A., Geisel J., Halushka P. V., Reines H. D. Prostaglandins, thromboxanes, leukotrienes, and cytochrome P045- metabolites of arachidonic acid. New Horiz. 1:1993;60-69.
33. Cooper I., Lord T., Tice P. A. Hydrolysis studies on oleamide in stimulated gastrointestinal fluids. Food Addit. Contam. 12:1995;769-777.
34. Coscina D. V., Yehuda S., Kish S. J., Leprohon-Greenwood C. E. Learning is improved by soybean oil diet in rats. Life Sci. 38:1986;1789-1794.
35. Cravatt B. F., Lerner R. A., Boger D. L. Structure determination of an endogenous sleep-inducing lipids, cis-9-octadecenamide (oleamide) a synthetic approach to the chemical analysis of trace quantities of a natural product . J. Am. Chem. Soc. 118:1996;580.
36. Cravatt B. F., Prospero-Garcia O., Siuzdak G., Gilula N. B., Henriksen S. J., Boger D. L., Lerner R. A. Chemical characterization of a family of brain lipids that induce sleep. Science (Washington DC). 268:1995;1506-1509.
37. Dalcik H., Phelps C. J. Median eminence-afferent vascoactive intestinal peptide (VIP) neurons in the hypothalamus localization by simultaneous tract tracing and immunocytochemistry . Peptides. 14:1993;1059-1066.
38. Davis P. J. n-3 and n-6 polyunsaturated fatty acids have different effects on acyl-CoA cholesterol acyltransfered in fatty macrophages . Biochem. Cell Biol. 70:1992;1313-1318.
39. Delion S., Chalon S., Guilloteau D., Besnard J. C., Durand G. Alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J. Neurochem. 66:1996;1582-1591.
40. Dhopeshwarkar G. A. Nutrition and brain development. 1983;35-37 Plenum, New York.
41. Doucet J. P., Bazan N. G. Excitable membranes, lipid messengers, and immediate-early genes Alternation of signal transduction in neuromodulation and neurotrauma . Mol. Neurobiol. 6:1992;407-424.
42. Ellis E., Police R. J., Dodson L. Y., McKinney J. C., Holt S. A. Effect of dietary n-3 fatty acids on cerrebral microcirculation. Am. J. Physiol. 262:1992;H1379-H1386.
43. Emmerling M. R., Dudley D. T., Dyer R. D., Carroll R. Y., Doyle P. D., Davis R. E. The role of arachidonic acid in the secretion of the amyloid precursor protein (APP). Ann. NY Acad. Sci. 777P:1996;310-315.
44. Engstrom G., Alsen M., Regnell G., Traskamn-Bendz L. Serum lipids in suicide attempts. Suicide Life Threat. Behav. 25:1995;393-400.
45. Enslen M., Milon H., Malone A. Effects of low intake of n-3 fatty acid during development on brain phospholipid fatty acid composition and exploratory behavior in rats. Lipids. 26:1991;203-208.
46. Fadda P., Martellotta M. C., De Montis M. G., Gessa G. L., Fratta W. Dopamine D1 and opioid receptor binding changes in the limbic system of sleep deprived rats. Neurochem. Int. 20:1992;153S-156S.
47. Fadda P., Martellotta M. C., Gessa G. L., Fratta W. Dopamine and opioid interactions in sleep deprivation. Prog. Neuropsychopharmacol. Biol. Psychiatry. 17:1993;269-278.
48. Faletti A., Viggiano J. M., Gimeno M. A. Beta-endorphin inhibits prostaglandin synthesis in rat ovaries and blocks induced ovulation. Prostaglandins. 49:1995;93-103.
49. Farooqui A. A., Horrocks L. A. Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders. Brain Res. Rev. 16:1991;171-191.
50. Fleisher-Berkovich S., Danon A. Effect of corticotropin-releasing factor on prostaglandin synthesis in endothelial cells and fibroblasts. Endocrinology. 136:1995;4068-4072.
51. Forget H., Painson J. C., Drews R. T., Lagace G., Collu R. MMQ cells a model for evaluating the role of G proteins in the modulation of prolactin release . Mol. Cell. Endocrinol. 93:1993;125-133.
52. Ganong W. F. Blood, pituitary and brain renin-angiotensin systems and regulation of secretion of anterior pituitary gland. Front. Neuroendocrinol. 14:1993;233-249.
53. Gelfand R. A., Wepsic H. T., Parker L. N., Jadus M. R. Prostaglandin E2 induces up-regulation of murine macrophage beta-endorphin receptors. Immunol. Lett. 45:1995;143-148.
54. Hammond P. J., Talbot K., Chapman R., Ghatei M. A., Bloom S. R. Vasoactive intestinal peptide, but not pituitary adenylate cylase-activating peptide, modulates the responsiveness of the gonadotroph to LRHR in man. J. Endocrinol. 137:1993;529-532.
55. Hargreaves K., Clandinin M. T. Dietary lipids in relation to postnatal development of the brain. Ups. J. Med. Sci. 48:1990;79-95.
56. Hasegaw J., Loh H. H., Lee N. M. Lipid requirement for mu opioid receptor binding. J. Neurochem. 49:1987;1007-1012.
57. Hashimoto M., Gong X. W., Izaki Y., Iriki M., Hibino H. 1-Oleoyl-2-docosahexaenoyl phosphatidylcholine increased paradoxical sleep in F344 rats. Neurosci. Lett. 158:1993;29-32.
58. Horrocks L. A., Harder H. W. Fatty acids and cholesterol. Lajtha A. Handbook of neurochemistry. 1983;1-16 Plenum, New York.
59. Houben H., Denef C. Unexpected effects of peptide and nonpeptide substance P receptor antagonists on basal prolactin and growth hormone release in vitro. Peptides. 14:1993;109-115.
60. Houslay, M. D.; Stanley, K. K. Dynamics of biological membrane. New York: J. Wiley; 1982;135-137.
61. Huang Y. S., Koba K., Horrobin D. F., Sugano M. Interrelationship between dietary protein, cholesterol and n-6 polyunsaturated fatty acid metabolism. Prog. Lipid Res. 32:1993;123-137.
62. Huidobro-Toro J. P., Adron H. R. Brain lipids that induce sleep are novel modulators of 5-hydroxytryptamine receptors. Proc. Natl. Acad. Sci. USA. 93:1996;8078.
63. Hussain S. T., Roots B. I. Effects of essential fatty acid deficiency & immunopathological stresses on blood brain barrier (B-BB) in Lewis rats a biochemical study . Biochem. Soc. Trans. 2:1994;338S.
64. Igarashi N., Sato T. Free fatty acid responses to growth hormone (GH)-releasing factor and the GH-GH receptor axis. Nippon Naibunpi Gakkai Zasshi. 69:1993;149-157.
65. Ikawa H., Yamamoto K., Takahashi Y., Ueda N., Hayashi Y., Yamamoto S., Ishimura K., Irahara M., Aono T. Arachidonate 12-lipoxygenase in porcine anterior pituitary cells its localization and possible function in gonadotrophs . J. Endocrinol. 148:1996;33-41.
66. Joo, F. Brain microvascular cyclic nucleotides and protein phosphorylation. In: Pardridge, W. M., Ed. Blood brain barrier. Cellular and molecular Biology. New York: Raven Press; 1993:267-287.
67. Jorgensen C., Sany J. Modulation of the immune response by the neuro-endocrine axis in rheumatoid arthritis. Clin. Exp. Rheumatol. 12:1994;435-551.
68. Judd A. M. Vasoactive intestinal peptide increases the liberation of arachidonate from the anterior pituitary cells in vitro. Life Sci. 57:1995;1641-1646.
69. Judd A. M., Koike K., MacLeod R. M. GRF increases release of growth hormone and arachidonate from anterior pituitary cells. Am. J. Physiol. 248:1985;E438-E442.
70. Judd A. M., MacLeod R. M. Thyrotrophin-releasing hormone and lysine-bradykinin stimulate arachidonate liberation from rat anterior pituitary cells through different mechanisms. Endocrinology. 131:1992;1251-1260.
71. Judd A. M., Vernon L. P., MacLeod R. M. Pyrularia thionin increases arachidonate liberation and prolactin and growth hormone release from anterior pituitary cells. Toxicon. 30:1992;1563-1573.
72. Kacsoh B., Toth B. E., Avert L. M., Grosvenor C. E. In vitro control of prolactin (PRL) and growth hormone secretion of neonatal rat pituitary glands effects of bovine PRL, salmon calcitonin, endothelin-3, angiotensin II, bromocryptine and somatostatin . Life Sci. 52:1993;259-269.
73. Kanthasamy A. G., Borowitz J. L., Pavlakovic G., Isom G. E. Dopaminergic neurotoxity of cyanide neurochemical, histological, and behavioral characterization . Toxicol. Appl. Pharmacol. 126:1994;156-163.
74. Kaplan J. R., Shively C. A., Fontenot M. B., Morgan T. M., Howell S. M., Manuck X. B., Muldoon M. F., Mann J. J. Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys. Psychosom. Med. 56:1994;479-484.
75. Karanth S., Lyson K., Aguila M. C., McCann S. M. Effects of luteinizing-hormone-releasing hormone, alpha-melancoyte-stimulating hormone, naloxone, dexamethasone and indomethacin on interleukin-2-induced corticotropin-releasing factor release. Neuroimmunomodulation. 2:1995;166-173.
76. Kennedy J. A., Nicolson R., Wellby M. L. The effect of oleic acid on the secretion of thyrotrophin and growth hormone by cultured rat anterior pituitary cells. J. Endocrinol. 143:1994;557-564.
77. Kerttula T., Kaukinen S., Riutta A., Seppala E., Mucha I., Vapaatalo H., Alanko J. Effects of noradrenaline and dopamine infusions on arachidonic acid metabolism in man. Thromb. Res. 80:1995;169-178.
78. Kerttula T., Riutta A., Kakinen S., Metsa-Ketela T., Seppala E., Vapaatalo H., Alanko J. Noradrenaline and dopamine infusions modulate arachidonic acid cyclooxygenase and 5-lipoxygenase pathways ex vivo in man. Prostaglandins. Leokot Essent. Fatty Acids. 53:1995;47-52.
79. Kessler A. R., Yehuda S. Learning-induced changes in brain membrane fluidity implications for the mechanism of aging of the brain . Int. J. Neurosci. 28:1985;73-82.
80. Kiesel L., Przylipiak A., Emig E., Rabe T., Runnebaum B. Stimulation of gonadotropin release by arachadonic acid and its lipoxygenase metabolites in superfused pituitary cells. Life Sci. 40:1987;847-851.
81. Kinney H. C., Panigrahy A., Rava L. A., White W. F. Three-dimensional distribution of [3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in the developing human brain stem. J. Comp. Neurol. 362:1995;350-367.
82. Knickle L. C., Bend J. R. Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung the orthologue of cytochrome P450 2B4 is solely responsible for formation of epoxyeicostrienoic acids . Mol. Pharmacol. 45:1994;1273-1280.
83. Kolocouris N., Foscolos G. B., Fytas G., Sakellariou A., Raftopoulos C., Papadopoulou-Daifoti Z., Vamvakides A. Dopamine amides with essential or fundamental fatty acids Synthesis and pharmacological study . Ann. Pharm. Fr. 49:1991;99-110.
84. Krueger J. M., Kubillus S., Shoham S., Davenne D. Enchantment of slow-wave sleep by endotoxin and lipid A. Am. J. Physiol. 251:1986;R591-R597.
85. L'hirondel M., Cheramy A., Godeheu G., Glowinski J. Effects of arachidonic acid (AA) on dopamine synthesis, spontaneous release, and uptake in striatal synaptosomes from the rat. J. Neurochem. 64:1995;1406-1409.
86. Lacroix S., Rivest S. Role of cyclo-oxygenase pathways in the stimulatory influence of immune challenge on the transcription of a specific crf receptor subtype in the rat brain. J. Chem. Neuroanat. 10:1996;53-71.
87. Laufuente A., Marco J., Esquifino A. I. Physiological roles of thyrotrophin-releasing hormone and vasoactive intestinal peptide on the pulsatile secretory patterns of prolactin in pituitary-grafted female rats. J. Endocrinol. 142:1994;581-586.
88. Lange K. W., Rausch W. D., Gsell W., Naumann M., Oestreicher E., Reiderer P. Neuroprotection by dopamine agonists. J. Neural Transm. Suppl. 43:1994;183-201.
89. Lerner R. A., Siuzdak G., Prospero-Garcia O., Henriksen S. J., Boger D. L., Cravatt B. F. Cerebrodiene a brain lipid isolated from sleep-deprived cats . Proc. Natl. Acad. Sci. USA. 91:1994;9505-9508.
90. Lyson, K.; McCann, S. M. Involvement of arachidonic acid cascade in interleukin-6-stimulated corticotropin-releasing factor release in vitro. Neuroendocrinology. 55:708-703; 1992.
91. Makita K., Falck J. R., Capdevila J. H. Cytochrome P450, the arachadonic acid cascade and hypertension new vistas for an old enzyme system . FASEB J. 10:1996;1456-1463.
92. Malnoe A., Milon H., Reme C. Effect of in vivo modulation of membrane docosahexaenoic acid levels on the dopamine-dependent adenylate cyclase activity in the rat retina. J. Neurochem. 55:1990;1480-1485.
93. Martinez de la Escalera G., Weiner R. I. Dissociation of dopamine form its receptor as a signal in the pleiotropic hypothalamic regulation of prolactin secretion. Endocr. Rev. 13:1922;241-255.
94. Matsuo T., Sumida H., Suzuki M. Beef tallow diet decreases norepinephrine turnover rates in rat hypothalamus and cerebral cortex. Metabolism. 44:1995;1377-1979.
95. McGee C. D., Greenwood C. E. Effects of dietary fatty acid composition on macronutrient selection and synaptosomal fatty acid composition in rats. Life Sci. 47:1990;933-937.
96. Miura T., Muraoka S., Ogiso T. Lipid peroxidation inhibited by monoamines. Res. Comm. Mol. Pathol. Pharmacol. 93:1996;57-67.
97. Methot N., Demers C. N., Baenziger J. E. Structure of both the ligand-and-lipid-dependent channel-inactive states of the nicotinic acetylcholine receptor probed by FTIR spectroscopy and hydrogen exchange. Biochemistry. 34:1995;15142-15149.
98. Muller-Wieland D., Behnke B., Koopman K., Krone W. Melatonin inhibits LDL receptor activity and cholesterol synthesis in freshly isolated human monocular leukocytes. Biochem. Biophys. Res. Commun. 203:1994;416-421.
99. Murphy M. G., Moak C. M., Rao B. G. Effects of membrane polyunsaturated fatty acids on opiate peptide inhibition of basal and prostaglandin E1-stimulated cyclic AMP formation in intact NIE-115 neurometabolism cells. Biochem. Pharmacol. 36:1987;4079-4084.
100. Myers M., Freire E. Calorimetric and fluorescence characterization of interactions between enkephalins and liposomal and synaptic plasma membranes containing gangliosides. Biochemistry. 24:1995;4076-4082.
101. Naor Z. Signal transduction mechanisms of Ca2+ mobilizing hormones the case of gonadotropin-releasing hormone . Endocr. Rev. 11:1990;326-353.
102. Narial T., DeGeorge J. J., Greig N. H., Genka S., Rapoport S. I., Purdon A. D. Differences in rates of incorporation of intravenously injected radiolabeled fatty acids into phospholipids of intracerebrally implanted tumor and brain in awake rats. Clin. Exp. Metastasis. 12:1994;213-225.
103. Nilsson C., Erikson E. Partial dopamine D2 receptor agonists antagonize prolactin-regulating D2 receptors in a transfixed clonal cell line (GH4ZR7). Eur. J. Pharmacol. 218:1992;205-211.
104. Noda Y., Rodriquez-sierra J., Liu J., Landers D., Mori A., Paul S. Partitioning of vasoactive intestinal polypeptide into lipid bilayers. Biochem. Biophys. Acta. 1191:1994;324-330.
105. Obal F. Jr, Payne L., Kascsoh B., Opp M., Kapas L., Grosvenor C. E., Krueger J. M. Involvement of prolactin in the REM sleep-promoting activity of systemic vasoactive intestinal peptide (VIP). Brain Res. 645:1994;143-149.
106. Oka T., Aou S., Hori T. Intracerebroventricular injection of interleukin-1 beta induces hyperalgesia in rats. Brain Res. 624:1993;61-68.
107. Ongini E., Bonizzoni E., Ferri N., Milani S., Trampus M. Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat. J. Pharmacol. Exp. Ther. 266:1993;726-731.
108. Pacheco M. A., Jope R. S. Phosphoinositide signaling in human brain. Prog. Neurobiol. 50:1996;255-273.
109. Palmer A. M., DeKosky S. T. Monoamine neurons in aging and Alzheimer's disease. J. Neural. Transm. Gen. Sect. 91:1993;135-159.
110. Patcher V., Dishkelov A. Effects of vasopressin on the brain lipid metabolism during learning and retention of conditional avoidance behavior. Acta Physiol. Pharmacol. Bulg. 13:1987;51-55.
111. Patterson J. E., Ollman I. R., Cravatt B. F., Boger D. L. Inhibition of oleamide hydrolase catalyzed hydrolysis of the endogenous sleep-inducing lipid cis-9-octadecenamide. J. Am. Chem. Soc. 118:1996;5938.
112. Pertinhez T. A., Nakaie C. R., Carvalho R. S., Paiva A. C., Tabak M., Toma F., Schreier S. Conformational changes upon binding of a receptor loop to lipid structures possible role in signal transduction . FEBS Lett. 375:1995;239-242.
113. Petraglia F., Benedetto C., Florio P., D'Ambrogio G., Genazzani A. D., Marozio L., Vale W. Effect of corticotropin-releasing factor-binding protein on prostaglandin release from cultured maternal decidua and on contractile activity of human myometrium in vitro. J. Clin. Endocrinol. Metab. 80:1995;3073-3076.
114. Raber J., Koob G. F., Bloom F. E. Interleukin-2 induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling comparison with the hypothalamic response . J. Pharmacol. Exp. Ther. 272:1995;815-824.
115. Rapoport S. I. In vivo labeling of brain phospholipids by long-chain fatty acids relation to turnover and function . Lipids. 31:1996;S97-101.
116. Rego A. C., Oliveira C. R. Influence of lipid peroxidation on [3H] ketanserin binding to 5-HT2 prefrontal cortex receptors. Neurochem. Int. 27:1995;489-496.
117. Rikhireva G. T., Makletsova M. G., Mendzherkitskii A. M., Vartanian L. S., Gurevich S. M., Lozovskaia E. L., Kopylovskii S. A., Rylova A. V., Prudchenko I. A., Mikhaleva I. I. Changes in the intensity of free-radical reactions in the organds of rats under hypokinetic stress and with protection by the delta sleep-inducing peptide and its tyrosine-containing analog. Izv. Akad. Nauk. Ser. Biol. 2:1993;243-256.
118. Rivier C. Influence of immune signals on the hypothalamic-pituitary axis of the rodent. Front. Neurodocrinol. 16:1995;151-182.
119. Roky R., Obal F. Jr, Valtax J. L., Bredow S., Fang J., Pagano L. P., Krueger J. M. Prolactin and rapid eye movement sleep regulation. Sleep. 18:1995;536-542.
120. Rosolowsky M., Falck J. R., Campbell W. B. Metabolism of arachidonic acid by canine polymorphonuclear leukocytes synthesis of lipoxygenase and omega-oxidized metabolites. Biochim. Biophys. Acta. 1300:1996;143-150.
121. Roundbaraki M. M., Drouhault R., Bacquart T., Vacher P. Arachidonic acid-induced hormone release in somatotropes involvement of calcium . Neuroendocrinology. 63:1996;244-256.
122. Roundbaraki M. M., Vacher P., Drouhault R. Arachidonic acid increases cytosolic calcium and stimulates hormone release in rat lactotrophs. Am. J. Physiol. 268:1995;E1215-E1223.
123. Salem N. Jr, Niebyski C. D. The nervous system has an absolute molecular species requirement for proper function. Mol. Membr. Biol. 12:1995;131-134.
124. Salvati S., Campeggi L. M., Sorcinni M., Olivieri A., DiBase A. Effects of propylthiouracial-induced hypothyroidism on membranes on adult rat brain. Lipids. 28:1993;1075-1078.
125. Samochocki M., Strosznajder J. The negative coupling between serotonin and muscarinic receptor(s) for arachidonic acid and inositol phosphates release in brain cortex synaptoneurosomes Effect of aging . Neurochem. Int. 26:1995;572-578.
126. Sazontova T. G., Golantsova N. E., Kolmykova S. N., Arkhangel' Skaia M. I., Koshatskaia I. L., Arkhipenko M. I. Effect of delta sleep-inducing peptide on the status of the calcium transport system of the sarcoplasmic reticular and activity of antioxidant defense enzymes in the myocardium. Biull. Eksp. Biol. Med. 121:1996;248-251.
127. Schwyzer R. 100 years lock-and-key concept are peptides keys shaped and guided to their receptors by the target cell membrane? Biopolymers. 37:1995;5-16.
128. Schwyzer R. Estimated membrane structure and receptor subtype selection of an opioid alkaloid-peptide hybrid. Int. J. Pept. Protein. Res. 32:1988;476-483.
129. Scott B. L., Bazan N. G. Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc. Natl. Acad. Sci. USA. 86:1989;2903-2907.
130. Señaris R. M., Lewis M. D., Lago F., Dominguez F., Scanlon M. F., Dieguez C. Effects of free fatty acids on somatostatin secretion, content and mRNA levels in cortical and hypothalamic fetal rat neurons in monolayer culture. J. Mol. Endocrinol. 10:1993;207-214.
131. Shashoua V. E., Hesse G. W. N-docosahexaenoyl, 3 hydroxytyramine a dopaminerguc compound that penetrates the blood-brain barrier and suppresses appetite . Life Sci. 58:1996;1347-1357.
132. Shmalwko I. P.; Mikhaleva, I. I. Antimetastatic effect of the delta-sleep peptide during stress in mice with Lewis lung carcinoma. Eksp. Onkol. 10:57-60; 1988.
133. Shmalwko I. P., Mikhaleva I. I. Antimetastatic affect of the delta-sleep peptide during stress in mice with Lewis lung carcinoma. Eksp. Onkol. 11:1988;37-61.
134. Signs S. A., Dluzen D. E., Carrillo A. J. Para-chlorohenylalanine treatment inhibits the expression of vasoactive intestinal peptide messenger RNA in rat anterior pituitary. Brain. Res. Mol. Brain. Res. 17:1993;36-40.
135. Signs S. A., Liu B., Wolford J., Carrillo A. J. Serotonergic involvement in the regulation of prolactin and vasoactive intestinal peptide mRNA expression in the rat anterior pituitary. Mol. Cell. Endocrinol. 105:1994;183-191.
136. Spangelo B. L., Jarvis W. D., Judd A. M., MacLeod R. M. Induction of interleukin cells in vitro evidence for an eicosanoid-dependent mechanism . Endocrinology. 129:1991;2886-2894.
137. Spector R. Fatty acid transport through the blood-brain barrier. J. Neurochem. 50:1988;639-643.
138. Stepniakowski K. T., Goodfriend T. L., Egan B. M. Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension. 25:1995;774-778.
139. Stromstedt M., Warner M., Gustafsson J. A. Cytochrome P450s of the 4A subfamily in the brain. J. Neurochem. 63:1994;671-676.
140. Stronsznajder J., Samochocki M., Duran M. Aging diminishes serotonin-stimulated arachidonic acid uptake and cholinergic receptor-activated arachidonic acid release in rat brain cortex membrane. J. Neurochem. 62:1994;1048-1054.
141. Strosznajder J., Samochocki M., Duran M. Serotonin, a potent modulator of arachidonic acid turnover, interaction with glutamatergic receptor in brain cortex. Neurochem. Int. 25:1994;193-199.
142. Suto G., Kiraly A., Tache Y. Interleukin 1 beta inhibits gastric emptying in rats mediation through prostaglandin and corticotropin-releasing factor . Gastroenterology. 106:1994;1568-1575.
143. Thompson A. B. R., Keelan M., Clandinin M. T. Feeding rats a diet enriched with saturated fatty acids presents the inhibitory effects of acute and chronic ethanol exposure on the in vitro uptake of hexoses and lipids. Biochem. Biophys. Acta. 1084:1991;122-128.
144. Trampus M., Ferri N., Adami M., Ongini E. The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat. Eur. J. Pharmacol. 235:1993;83-87.
145. Trampus M., Ongini E. The D1 dopamine receptor antagonist SCH 23390 enhances REM sleep in the rat. Neuropharmacology. 29:1990;889-893.
146. Vaidyanathan V. V., Rao K. V., Sastry P. S. Regulation of diacylglycerol kinase in rat brain membranes by docosahexaenoic acid. Neurosci. Lett. 179:1994;171-174.
147. Vanhatalo S., Soinila S., Kaartinen K., Back N. Colocalization of dopamine and serotonin in the rat pituitary gland and in the nuclei innervating it. Brain Res. 669:1995;275-284.
148. VanRollins M., Kaduce T. L., Fang X., Knapp H. R., Spector A. A. Arachidonic acid diols produced by cytochrome P-450 monooxygenases are incorporated into phospholipids of vascular endothelial cells. J. Biol. Chem. 271:1996;14001-14009.
149. Vial D., Piomelli D. Dopamine D2 receptors potentiate arachidonate release via activation of cytosolic, arachidonate-specific phospholipase A2. J. Neurochem. 64:1995;2765-2772.
150. Wainwright P. E. Essential fatty acids and behavior is there a role for the eicosanoids . Yehuda S, Mostosky D. Handbook of essential fatty acid biology, biochemistry physiology, and behavioral neurobiology. 1997;299-341 Humana Press, New York.
151. Wang S. W., Wang M., Grossman B. M., Martin R. J. Effects of dietary fat on food intake and brain uptake and oxidation of fatty acids. Physiol. Behav. 56:1994;517-522.
152. Warner M., Stromstedt M., Wyss A., Gustafsson J. A. Regulation of cytochrome P450 in the central nervous system. J. Steroid Biochem. Mol. Biol. 47:1993;191-194.
153. Watanabe T., Clarck W. G., Ceriani G., Lipton J. M. Elevation of plasma ACTH concentration in rabbits made febrile by systemic injection of bacterial endotoxin. Brain Res. 652:1994;201-206.
154. Weindenfeld J., Feldman S., Mechoulam R. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalmo-pituitary-adrenal axis in the rat. Neuroendocrinology. 59:1994;110-112.
155. Widmaier E. M. Fatty acid regulation of endocrine activitty. Yehuda S., Mostosky D. Handbook of essential fatty acid biology, biochemistry physiology, and behavioral neurobiology. 1997;115-137 Humana Press, New York.
156. Woods B. T., Chiu T. M. Induced and spontaneous seizures in man produce increases in regional brain lipid detected by in vivo proton magnetic resonance spectroscopy. Adv. Exp. Med. Biol. 318P:1992;267-274.
157. Xu M., Proudman J. A., Pitts G. R., Wong E. A., Foster D. N., el Halawani M. E. Vasoactive intestinal peptide stimulates prolactin mRNA expression in turkey pituitary cells effects of dopaminergic drugs . Proc. Soc. Soc. Exp. Biol. Med. 212:1996;52-62.
158. Yamaguchi K., Hama H. Evaluation for roles of brain prostaglandins in the catecholamine-induced vasopressin secretion in conscious rats. Brain Res. 607:1993;149-153.
159. Ye H., Wolf R. A., Kurz T., Corr P. B. Phosphatidic acid increases in response to noradrenaline and endothelin-1 in adult rabbit ventricular myocytes. Cardiovasc. Res. 28:1994;1828-1834.
160. Yehuda S., Carasso R. L., Mostofsky D. I. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur. J. Pharmacol. 254:1994;193-198.
161. Yehuda S., Carraso R. L. Modulation of learning pain thresholds, and thermoregulation in the rat by preparations of free- purified α-linolenic and linoleic acids determination of the optimal w3-to w6 ratio . Proc. Natl. Acad. Sci. USA. 90:1993;10345-10349.
162. Yehuda S., Carraso R. L., Mostofsky D. I. Essential fatty acid preparation (SR-3) rehabilitates learning deficits induced by AF64A and 5,7-DHT. NeuroReport. 6:1995;511-515.
163. Yehuda S., Leprohon-Greenwood C. E., Dixon L. M., Coscina D. V. Effects of dietary fat on pain threshold, thermoregulation and motor activity in rats. Pharmacol. Biochem. Behav. 24:1986;1775-1777.
164. Yehuda S., Rabinoitz S., Mosotfsky D. I. Effects of essential fatty acid preparation (SR-3) on brain lipids, biochemistry and behavioral and cognitive functions. Yehuda S., Mostosky D. Handbook of essential fatty acid biology, biochemistry physiology, and behavioral neurobiology. 1997;427-452 Humana Press, New York.
165. Yehuda, S.; Rabinovitz, S.; Mostofsky, D. Essential fatty acids and sleep: mini review and hypothesis. Med. Hypotheses 1997 (in press).
166. Yoneda M., Tache Y. Central thyrotrophin-releasing factor analog prevents ethanol-induced gastric damage through prostaglandins in rats. Gastroenterology. 102:1992;1568-1574.
167. Yu N., Martin J. L., Stella N., Magistretti P. J. Arachidonic acid stimulates glucose uptake in cerebral cortical astrocytes. Proc. Natl. Acad. Sci. USA. 90:1993;4042-4046.
168. Yukhananov R., Rebrov I., Tennila T., Maisky A. Effect of ethanol and